These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25743726)

  • 1. Effect of palonosetron (5HT-3 antagonist) and pantoprazole (proton pump inhibitor) against surgical esophagitis induced by forestomach and pylorus ligation in albino rats.
    Kumar A; Gautam S; Rawat JK; Singh M; Saraf SA; Kaithwas G
    Hum Exp Toxicol; 2016 Jan; 35(1):41-50. PubMed ID: 25743726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy of gabapentin with pantoprazole exhibited better protective action against forestomach and pylorus ligation-induced gastric esophageal reflux disease in albino Wistar rats.
    Arya P; Kaithwas G
    Hum Exp Toxicol; 2020 Apr; 39(4):492-499. PubMed ID: 31868530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of monotherapy and combination therapy of pantoprazole and aprepitant in gastric esophageal reflux disease in albino rats.
    Shukla K; Raj P; Kumar A; Kumar M; Kaithwas G
    ScientificWorldJournal; 2014; 2014():183147. PubMed ID: 24790551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lycopene against gastroesophageal reflux disease in experimental animals.
    Giri AK; Rawat JK; Singh M; Gautam S; Kaithwas G
    BMC Complement Altern Med; 2015 Apr; 15():110. PubMed ID: 25888837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Perilla frutescens fixed oil on experimental esophagitis in albino Wistar rats.
    Arya E; Saha S; Saraf SA; Kaithwas G
    Biomed Res Int; 2013; 2013():981372. PubMed ID: 24027769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rutin against gastric esophageal reflux in experimental animals.
    Kumar S; Singh M; Rawat JK; Gautam S; Saraf SA; Kaithwas G
    Toxicol Mech Methods; 2014 Dec; 24(9):666-71. PubMed ID: 25191975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ethanolic extract of Quisqualis indica L. flower on experimental esophagitis in albino Wistar rats.
    Singh S; Rai A; Maity S; Sarkar S; Maji S; Saha S
    Indian J Exp Biol; 2017 Feb; 55(2):122-6. PubMed ID: 30184413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of gamma-aminobutyric acid derivative promotes proton pump inhibitor based healing of reflux esophagitis in animal model.
    Khinchi P; Saha S; Saraf SA; Kaithwas G
    Pharmacol Rep; 2014 Feb; 66(1):165-8. PubMed ID: 24905323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Linum usitatissimum (linseed/flaxseed) fixed oil on experimental esophagitis in albino rats.
    Renu N; Kaithwas G; Ramteke PW; Saraf SA
    Acta Gastroenterol Belg; 2012 Sep; 75(3):331-5. PubMed ID: 23082704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1/2, PKA and PKC activation.
    Darmani NA; Zhong W; Chebolu S; Mercadante F
    Pharmacol Biochem Behav; 2015 Apr; 131():104-11. PubMed ID: 25687374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk.
    Blitz JD; Haile M; Kline R; Franco L; Didehvar S; Pachter HL; Newman E; Bekker A
    Am J Ther; 2012 Sep; 19(5):324-9. PubMed ID: 21519222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
    Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
    J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.
    Kaushal J; Gupta MC; Kaushal V; Bhutani G; Dhankar R; Atri R; Verma S
    Singapore Med J; 2010 Nov; 51(11):871-5. PubMed ID: 21140114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palonosetron (Helsinn).
    Stacher G
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1502-7. PubMed ID: 12431027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
    Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
    Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.
    Navari RM
    Future Oncol; 2006 Oct; 2(5):591-602. PubMed ID: 17026451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
    Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
    Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
    Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
    Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.